How Can Medtronic Gain With The Development Of Hybrid Closed Loop System For Type-1 Diabetes?

At the forefront of the development of a hybrid closed loop system for controlling type-1 diabetes is Medtronic , which is likely to launch the product by as soon as 2017. As compared to a conventional insulin pump, the hybrid closed loop, which is also being termed as artificial pancreas, will have a fully automated sensor which can automatically suspend insulin delivery when sensor glucose levels are predicted to approach a low limit, and automatically resume insulin delivery once sensor gluco...